首页> 外文期刊>Regulatory peptides. >Increased prolyl endopeptidase activity in human neoplasia.
【24h】

Increased prolyl endopeptidase activity in human neoplasia.

机译:在人类肿瘤中增加脯氨酰内肽酶的活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Prolyl endopeptidase (EC 3.4.21.26) (PEP) is a serine peptidase that converts several biologically active peptides. This enzyme has been linked to several neurological, digestive, cardiovascular and infectous disorders. However, little is known about its involvement in neoplastic processes. This study analyzes fluorimetrically cytosolic and membrane-bound PEP activity in a large series (n=122) of normal and neoplastic tissues from the kidney, colon, oral cavity, larynx, thyroid gland and testis. Cytosolic PEP activity significantly increased in clear cell renal cell carcinoma, urothelial carcinoma of the renal pelvis and head and neck squamous cell carcinoma. Both cytosolic and membrane-bound PEP activity were also increased in colorectal adenomatous polyps. These data suggest the involvement of PEP in some mechanisms that underlie neoplastic processes.
机译:脯氨酰内肽酶(EC 3.4.21.26)(PEP)是一种丝氨酸肽酶,可转换几种生物活性肽。该酶与多种神经系统疾病,消化系统疾病,心血管疾病和感染性疾病有关。然而,关于其参与肿瘤形成过程的知之甚少。这项研究分析了来自肾脏,结肠,口腔,喉,甲状腺和睾丸的大量正常和肿瘤组织(n = 122)中的荧光测定细胞质和膜结合的PEP活性。在透明细胞肾细胞癌,肾盂尿路上皮癌和头颈部鳞状细胞癌中,胞质PEP活性显着增加。大肠腺瘤性息肉的胞质和膜结合的PEP活性也增加。这些数据表明PEP参与了肿瘤形成过程中的某些机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号